| Product NDC: | 0472-1738 |
| Proprietary Name: | Miconazole Nitrate |
| Non Proprietary Name: | Miconazole Nitrate |
| Active Ingredient(s): | 200 mg/1 & nbsp; Miconazole Nitrate |
| Administration Route(s): | VAGINAL |
| Dosage Form(s): | SUPPOSITORY |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0472-1738 |
| Labeler Name: | Actavis Mid Atlantic LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA073508 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20020903 |
| Package NDC: | 0472-1738-03 |
| Package Description: | 3 SUPPOSITORY in 1 CARTON (0472-1738-03) |
| NDC Code | 0472-1738-03 |
| Proprietary Name | Miconazole Nitrate |
| Package Description | 3 SUPPOSITORY in 1 CARTON (0472-1738-03) |
| Product NDC | 0472-1738 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Miconazole Nitrate |
| Dosage Form Name | SUPPOSITORY |
| Route Name | VAGINAL |
| Start Marketing Date | 20020903 |
| Marketing Category Name | ANDA |
| Labeler Name | Actavis Mid Atlantic LLC |
| Substance Name | MICONAZOLE NITRATE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |